Health

GLP-1 Drugs Show Personalized Potential

Updated 2026-07-31 11:10 UTC 1 source Neutral

A study suggests that GLP-1 drugs could be personalized for individual patients, leading to greater cardiometabolic improvements. The research focuses on higher-dosage GLP-1 agonists.

Coverage timeline — 1 article
The Hill
The higher-dosage GLP-1 agonists largely engendered greater cardiometabolic improvements.
2026-07-31 10:44 UTC
Share: Twitter / X LinkedIn